0000899243-16-021122.txt : 20160527
0000899243-16-021122.hdr.sgml : 20160527
20160527162159
ACCESSION NUMBER: 0000899243-16-021122
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160525
FILED AS OF DATE: 20160527
DATE AS OF CHANGE: 20160527
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CytomX Therapeutics, Inc.
CENTRAL INDEX KEY: 0001501989
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 343 OYSTER POINT BLVD.
STREET 2: SUITE 100
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650.515.3185
MAIL ADDRESS:
STREET 1: 343 OYSTER POINT BLVD.
STREET 2: SUITE 100
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SHANNON TIMOTHY M
CENTRAL INDEX KEY: 0001207114
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37587
FILM NUMBER: 161682678
MAIL ADDRESS:
STREET 1: C/O CURAGEN CORP
STREET 2: 555LONG WHARF DR. 11TH FL.
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-05-25
0
0001501989
CytomX Therapeutics, Inc.
CTMX
0001207114
SHANNON TIMOTHY M
285 RIVERSIDE AVENUE
SUITE 250
WESTPORT
CT
06880
1
0
0
0
Common Stock
2016-05-25
4
S
0
11456
10.02
D
4551359
I
See Footnote
Common Stock
2016-05-26
4
S
0
39887
10.43
D
4511472
I
See Footnote
Common Stock
134
D
These shares of Common Stock ("Shares") are held directly by Canaan IX L.P. The Reporting Person is a non-managing member of Canaan Partners IX LLC, the general partner of Canaan IX L.P. The Reporting Person does not have voting, investment or dispositive power over any of the Shares directly held by Canaan IX L.P. and disclaims beneficial ownership of the Shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or for any other purpose.
The price reported in Column 4 is a weighted average price. These Shares were sold in multiple transactions at prices ranging from $10.00 - $10.085, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in footnote (2) of this Form 4.
The price reported in Column 4 is a weighted average price. These Shares were sold in multiple transactions at prices ranging from $10.00 - $10.74, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in footnote (3) of this Form 4.
Exhibit 24 - Power of Attorney (incorporated by reference to the Power of Attorney filed as Exhibit 24.1 to the Form 3 filed by the Reporting Person on October 7, 2015)
By: /s/ Cynthia J. Ladd, Attorney-in-Fact
2016-05-27